Publication | Closed Access

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease

Endovascular TechniqueCardiovascular DiseaseVascular SurgerySurgeryArterial DiseaseMedicineAtherosclerosisOrthopaedic SurgeryThree-year ResultsVibrant Trial